Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
O. Hovardovska (Kharkiv, Ukraine), O. Schevchenko (Kharkiv, Ukraine), I. Ovcharenko (Kharkiv, Ukraine). Ability of genotypical method to make assesment of tuberculosis infection hotbed. 4756

Member's Comments

No comment yet.

Related content which might interest you: Framework for the evaluation of new tests for tuberculosis infection Source: Eur Respir J, 58 (2) 2004078; 10.1183/13993003.04078-2020 Year: 2021 Assessment of the clinical utility of amplicor mycobacterium tuberculosis direct test during bacteriological confirmation of tuberculosis in children Source: Annual Congress 2008 - Specific tuberculosis management problems in children and adolescents Year: 2008 Comparison of performance in two diagnostic methods for M. tuberculosis infection Source: Annual Congress 2008 - New tools in tuberculosis diagnosis Year: 2008 Method of evaluation of tuberculocidal effectiveness of disinfectants in clinical strains of Mycobacterium tuberculosis Source: Annual Congress 2010 - Special treatment options in tuberculosis Year: 2010 Clinical evaluation of a diagnostic method of tuberculosis infection, QuantiFERON TB-2G, for active tuberculosis and nontuberculous mycobacteriosis Source: Eur Respir J 2006; 28: Suppl. 50, 139s Year: 2006 Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis Source: Eur Respir J 2010; 35: 338-342 Year: 2010 Standardised PCR-based molecular epidemiology of tuberculosis Source: Eur Respir J 2008; 31: 1077-1084 Year: 2008 Evaluation of non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis: Interim analysis of a TBNET study Source: Annual Congress 2012 - New developments in the immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2012 Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Combined phenotypical and functional analysis of M. tuberculosis specific immunity for diagnosing active infection and risk assessment in latently infected individuals Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014 Pan-genomic and immunomic identification of novel mycobacterium tuberculosis antigens for TB diagnosis Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for countries with a low tuberculosis burden Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces Year: 2016 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries Source: Eur Respir J 2015; 46: 1563-1576 Year: 2015 Routine survey of Mycobacterium tuberculosis isolates reveals nosocomial transmission Source: Eur Respir J, 55 (3) 1901888; 10.1183/13993003.01888-2019 Year: 2020 Comparative analysis of detection of Mycobacterium tuberculosis and rifampin resistance determination through microbiological and molecular genetics methods for pulmonary tuberculosis patients with presence or absence of sputum Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012 Performance of blood tests for the diagnosis of latent tuberculosis infection in children Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease Year: 2008 Microbiology of Mycobacterium tuberculosis and a new diagnostic test for TB Source: Eur Respir Mon 2012; 58: 1-13 Year: 2012 Development of a prognostic scoring system for Mycobacterium avium complex lung disease Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Evaluation of DestiNA ‘spin-tube’ technology – a novel test for the diagnosis of tuberculosis and mycobacteriosis Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis Year: 2020 Clinical usefulness of the DNA amplification method for early diagnosis of M. tuberculosis infection Source: Eur Respir J 2001; 18: Suppl. 33, 498s Year: 2001